maintrac Using the maintrac® method, the success of treatment can be monitored prior to, during and after therapy.
Cancer diseases The maintrac® method can be applied with almost every solid tumor, whereby it contributes to the treatment of each cancer type.
Breast cancer / Mamma carcinoma Both in adjuvant as well as in neoadjuvant therapy, maintrac® can help to monitor breast cancer therapy and make an optimization if required.
Prostate cancer / Prostate carcinoma In particular in the situation of watch-and-wait in prostate cancer, maintrac® can be applied for active surveillance.
Lung cancer / Bronchial carcinoma maintrac® is able to support the control of therapy success and helps choosing promising therapy strategies regarding the stage of disease and treatment.
Ovarian cancer / Ovarian carcinoma With the possibility of testing various substances with maintrac®, the patient already gets to know the substance most likely to be effective against the CETCs even before starting chemotherapy.
Colon cancer / Colon carcinoma With maintrac® the effectiveness of chemotherapeutic agents can already be tested prior to the colon cancer treatment.
Stomach cancer / Stomach carcinoma After cancer therapy is successfully accomplished, the calculated course of cell counts of maintrac® can be an indication wheter stomach cancer stays in remission or is about to return.
Malignant melanoma / Black skin cancer Basically the success of treatment in black skin cancer can be monitored through the number of circulating tumor cells in the blood.
Other types of cancer maintrac® can also be applied for further tumor types, such as sarcoma, to monitor the therapy and/or characterize the therapy-relevant properties.
Applications Apart from monitoring, maintrac® offers further advantages through the cell counting which can play a role for the optimization of cancer therapy.
Monitoring of therapy Through the accompanying determination of cell counts with maintrac®, it is possible to optimize and personalize the treatment during the whole course of disease.
Testing of medications With maintrac® it is possible to identify the drug which is likely to be most effective prior to the therapy.
Therapy-relevant characteristics Certain substances (targeted tumor therapies) only prove useful if tumor cells exhibit the relevant properties.
Early detection of new tumor activity An increase of circulating tumor cells (CETC / CTC) in the blood can be determined with maintrac® and may indicate new tumor activity.
Therapy situations maintrac® can serve as a significant tool in various therapy situations when making decisions regarding the subsequent treatment.
Neoadjuvant therapy In neoadjuvant therapy, maintrac® can assess the effectiveness of treatment and draw attention to relapses at an early stage.
Adjuvant therapy In addition to the monitoring of therapy success, maintrac® is able to identify medications which are most probable to be effective on the circulating tumor cells in the blood.
Metastatic situation In the metastatic situation, the maintrac® cell courses should be interpreted individually due to various possibilities of interpretation.
Watch-and-wait During the „watch and wait“ approach, maintrac® can keep a close check on tumor activity.
Download On this page, you can find out about how to receive the lab request form for maintrac®; you will also be provided with information on how the blood samples should be send.
Download On this page, you can find out about how to receive the lab request form for maintrac®; you will also be provided with information on how the blood samples should be send.
Information materials You can download our current information documents here. There you will learn about the applications of maintrac®.
Publications Obtain an overview Verschaffen Sie sich einen Überblick zu den wichtigsten Studien und Publikationen der letzten Jahre. Bei Fragen zur Literatur wenden Sie sich gerne direkt an uns.
News Stay informed!
On this page, we will keep you up-to-date on coming events at which our team is represented, as well as on current press releases.
Press Find out here the most recent press releases about maintrac® cancer diagnostics.
Events On this page we will keep you updated about upcoming events which we are participating.
FAQ maintrac® is a diagnostic laboratory method which allows us to calculate the number of circulating tumor cells in the blood.